Home Consular services Vaccination of Belgians abroad
Vaccination of Belgians abroad
The vaccination centers in Belgium have closed down in December 2022.
If you still need to vaccinate yourself, please inform yourself via the website of the region where you want to get the vaccine:
- For Flanders: www.laatjevaccineren.be
- for Brussels: www.vaccination-info.be; www ;www.coronavirus.brussels.be
- for Wallonia: www.covid.aviq.be/fr ; www.vaccination-info.be; www.Jemevaccine.be
- for the German-speaking community: www.ostbelgienlive.be
If you have been vaccinated in Indonesia or East Timor with a vaccine that is recognized in Belgium, this vaccination is also accepted in Belgium.
The following vaccines are now recognized by Belgium:
- Comirnaty (Pfizer/BioNTech) (2/2)
- Spikevax (Moderna) (2/2)
- Vaxzevria (AstraZeneca/Oxford), including dosses produced by Siam Bioscience (2/2)
- COVID-19 vaccin Janssen (Janssen) (1/1)
- Nuvaxovid (Novavax) (2/2)
- Covishield (Serum Institute of India) (2/2)
- Covovax (Serum institute of India) (2/2)
- CoronaVac (Sinovac Life Sciences) (2/2)
- Covaxin (Bharat Biotech International) (2/2)
- Inactivated COVID-19 Vaccine (Vero Cell) (Beijing Institute of Biological products) (Sinopharm) (2/2)
All doses of these vaccines should be administered as indicated in the instruction (see fractions above in brackets). Heterologous vaccinations (e.g. 1 dose AstraZeneca + 1 dose Pfizer) are not recognized as a complete vaccination scheme. Only when a 2nd dose of Pfizer is administered in this example, the vaccination scheme will be complete and recognized.
Following vaccination certificates are accepted by Belgium:
A. EU-COVID digital certificates of vaccination with a vaccine approved by the European Medicines Agency (EMA) or with a COVID-19 vaccine for which the World Health Organization (WHO) Emergency Use Listing procedure has been completed, if not more than 270 days have passed since the date of the last dose in the primary vaccination scheme, or evidence that a booster dose was administered after completion of the primary vaccination scheme.
B. Certificates of vaccination with EMA or WHO approved vaccines issued in a non-EU country that are considered equivalent by the European Commission on the basis of implementing acts, if not more than 270 days have passed since the date of the last dose in the primary vaccination scheme, or evidence that a booster dose was administered after completion of the primary vaccination series.
C. Vaccination certificates from third countries containing at least the following information in Dutch, French, German or English:
- data from which it can be deduced who is the person who has been vaccinated (name, date of birth and/or ID number));
- data showing that a vaccination was administered with an EMA or WHO approved vaccine;
- data showing that all doses specified in the instruction have been administered for at least two weeks and that no more than 270 days have elapsed since the date of the last dose in the primary vaccination scheme, or data showing that a booster dose after completion of the primary vaccination scheme was administered;
- the brand name and name of the manufacturer or trade license holder of each vaccine administered. If one of the two names is not mentioned, the lot number must also be mentioned;
- the date of administration of each dose of vaccine that was administered or the total number of doses and the name of the last vaccine that was administered, as well as the date of the last administration;
- the name of the country, province or region where the vaccination certificate was issued;
These vaccinations can subsequently be registered in vaccinet (via a general practitioner established in Belgium), and an EU covid vaccination certificate can be requested via the platform www.mijngezondheid.be
If the last dose of the primary vaccination scheme was administered more than 270 days ago, a booster dose must be administered for the vaccination certificate to remain valid. This booster can be any of the above vaccines, regardless of which vaccine was administered first. There are no exceptions to the validity condition of a booster dose.